Report Update Nov 1, 2024

Peru - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights

Single report

Sent by email within 24h (Mon-Fri)

$599 Basic Edition

$2095 Professional Edition

What's the difference?

Subscription

Online access and download

from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Peru: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Peru

In 2022, the Peruvian prophylactic medicaments containing insulin market increased by 8.5% to $X for the first time since 2019, thus ending a two-year declining trend. Over the period under review, consumption, however, continues to indicate resilient growth. Over the period under review, the market reached the maximum level at $X in 2019; however, from 2020 to 2022, consumption stood at a somewhat lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Peru

In 2022, after five years of growth, there was decline in overseas shipments of medicaments containing insulin but not antibiotics in measured doses, when their volume decreased by -0.6% to X kg. Overall, exports continue to indicate a deep reduction. The growth pace was the most rapid in 2013 when exports increased by 127% against the previous year. As a result, the exports attained the peak of X tons. From 2014 to 2022, the growth of the exports remained at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin exports stood at $X in 2022. In general, exports faced a abrupt decrease. The growth pace was the most rapid in 2014 when exports increased by 5.9%. Over the period under review, the exports attained the peak figure at $X in 2012; however, from 2013 to 2022, the exports remained at a lower figure.

Exports by Country

Bolivia (X kg) was the main destination for prophylactic medicaments containing insulin exports from Peru, accounting for a approx. 100% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of volume to Bolivia amounted to -5.9%.

In value terms, Bolivia ($X) also remains the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Peru.

From 2012 to 2022, the average annual growth rate of value to Bolivia amounted to -3.8%.

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, increasing by 2.6% against the previous year. In general, the export price, however, saw a deep setback. The pace of growth appeared the most rapid in 2015 an increase of 25% against the previous year. Over the period under review, the average export prices attained the maximum at $X per ton in 2012; however, from 2013 to 2022, the export prices stood at a somewhat lower figure.

As there is only one major export destination, the average price level is determined by prices for Bolivia.

From 2012 to 2022, the rate of growth in terms of prices for Bolivia amounted to +2.3% per year.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Peru

In 2022, the amount of medicaments containing insulin but not antibiotics in measured doses imported into Peru contracted slightly to X tons, which is down by -2.4% against 2021 figures. In general, imports, however, showed a noticeable increase. The growth pace was the most rapid in 2016 when imports increased by 133%. Over the period under review, imports hit record highs at X tons in 2019; however, from 2020 to 2022, imports stood at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin imports rose notably to $X in 2022. Overall, imports, however, recorded a buoyant expansion. The pace of growth appeared the most rapid in 2016 when imports increased by 221%. Over the period under review, imports attained the maximum at $X in 2019; however, from 2020 to 2022, imports remained at a lower figure.

Imports by Country

Germany (X tons), India (X tons) and Denmark (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Peru, together comprising 82% of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by India (with a CAGR of +21.1%), while imports for the other leaders experienced more modest paces of growth.

In value terms, Germany ($X), India ($X) and Denmark ($X) appeared to be the largest prophylactic medicaments containing insulin suppliers to Peru, together comprising 82% of total imports.

Among the main suppliers, India, with a CAGR of +44.8%, saw the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, with an increase of 15% against the previous year. In general, import price indicated a modest expansion from 2012 to 2022: its price increased at an average annual rate of +1.3% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, prophylactic medicaments containing insulin import price decreased by -10.3% against 2020 indices. The most prominent rate of growth was recorded in 2016 an increase of 38%. The import price peaked at $X per ton in 2020; however, from 2021 to 2022, import prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was the United States ($X per ton), while the price for China ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by India (+19.6%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in measured doses in the world?

The countries with the highest volumes of in 2021 were China, the United States and India, together accounting for 52% of global consumption.

What are the largest producers of medicaments containing insulin but not antibiotics in measured doses in the world?

The countries with the highest volumes of in 2021 were China, the United States and India, with a combined 52% share of global production.

What are the leading suppliers of medicaments containing insulin but not antibiotics in measured doses to Peru?

In value terms, Germany constituted the largest supplier of prophylactic medicaments containing insulin to Peru, comprising 38% of total imports. The second position in the ranking was occupied by India, with an 18% share of total imports. It was followed by Denmark, with an 18% share.

What are the leading importers of medicaments containing insulin but not antibiotics in measured doses from Peru?

In value terms, Bolivia $675) remains the key foreign market for prophylactic medicaments containing insulin exports from Peru, comprising 100% of total exports. The second position in the ranking was occupied by Canada $1), with a 0.1% share of total exports.

What is the average export price for medicaments containing insulin but not antibiotics in measured doses in Peru?

In 2021, the average prophylactic medicaments containing insulin export price amounted to $44,916 per ton, dropping by -8.1% against the previous year.

What is the average import price for medicaments containing insulin but not antibiotics in measured doses in Peru?

The average prophylactic medicaments containing insulin import price stood at $195,230 per ton in 2021, waning by -15% against the previous year.

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Peru. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale

Country coverage:

Peru

Data coverage:

Market volume and value
Per Capita consumption
Forecast of the market dynamics in the medium term
Trade (exports and imports) in Peru
Export and import prices
Market trends, drivers and restraints
Key market players and their profiles

Reasons to buy this report:

Take advantage of the latest data
Find deeper insights into current market developments
Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

How to diversify your business and benefit from new market opportunities
How to load your idle production capacity
How to boost your sales on overseas markets
How to increase your profit margins
How to make your supply chain more sustainable
How to reduce your production and supply chain costs
How to outsource production to other countries
How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business
1. REPORT DESCRIPTION
2. RESEARCH METHODOLOGY AND AI PLATFORM
3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
4. GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance
1. KEY FINDINGS
2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects
1. MARKET SIZE
2. MARKET STRUCTURE
3. TRADE BALANCE
4. PER CAPITA CONSUMPTION
5. MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO
1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
2. BEST-SELLING PRODUCTS
3. MOST CONSUMED PRODUCT
4. MOST TRADED PRODUCT
5. MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO
1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
2. TOP PRODUCING COUNTRIES
3. TOP EXPORTING COUNTRIES
4. LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO
1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
2. TOP CONSUMING MARKETS
3. UNSATURATED MARKETS
4. TOP IMPORTING MARKETS
5. MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry
1. PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
1. IMPORTS FROM 2012–2023
2. IMPORTS BY COUNTRY
3. IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
1. EXPORTS FROM 2012–2023
2. EXPORTS BY COUNTRY
3. EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO
LIST OF TABLES
1. Key Findings In 2023
2. Market Volume, In Physical Terms, 2012–2023
3. Market Value, 2012–2023
4. Per Capita Consumption In 2012-2023
5. Imports, In Physical Terms, By Country, 2012–2023
6. Imports, In Value Terms, By Country, 2012–2023
7. Import Prices, By Country Of Origin, 2012–2023
8. Exports, In Physical Terms, By Country, 2012–2023
9. Exports, In Value Terms, By Country, 2012–2023
10. Export Prices, By Country Of Destination, 2012–2023
LIST OF FIGURES
1. Market Volume, In Physical Terms, 2012–2023
2. Market Value, 2012–2023
3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
5. Trade Balance, In Physical Terms, 2012-2023
6. Trade Balance, In Value Terms, 2012-2023
7. Per Capita Consumption, 2012-2023
8. Market Volume Forecast to 2030
9. Market Value Forecast to 2030
10. Products: Market Size And Growth, By Type
11. Products: Average Per Capita Consumption, By Type
12. Products: Exports And Growth, By Type
13. Products: Export Prices And Growth, By Type
14. Production Volume And Growth
15. Exports And Growth
16. Export Prices And Growth
17. Market Size And Growth
18. Per Capita Consumption
19. Imports And Growth
20. Import Prices
21. Production, In Physical Terms, 2012–2023
22. Production, In Value Terms, 2012–2023
23. Imports, In Physical Terms, 2012–2023
24. Imports, In Value Terms, 2012–2023
25. Imports, In Physical Terms, By Country, 2023
26. Imports, In Physical Terms, By Country, 2012–2023
27. Imports, In Value Terms, By Country, 2012–2023
28. Import Prices, By Country Of Origin, 2012–2023
29. Exports, In Physical Terms, 2012–2023
30. Exports, In Value Terms, 2012–2023
31. Exports, In Physical Terms, By Country, 2023
32. Exports, In Physical Terms, By Country, 2012–2023
33. Exports, In Value Terms, By Country, 2012–2023
34. Export Prices, By Country Of Destination, 2012–2023